Navigation Links
Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
Date:1/31/2008

Foundation Continues Research Initiatives in Search of a Cure and Therapies

for Paralysis

SHORT HILLS, N.J., Jan. 31 /PRNewswire/ -- The Christopher and Dana Reeve Foundation (CDRF), which is dedicated to curing spinal cord injury by funding innovative research and improving the quality of life for people living with paralysis through grants, information and advocacy, today announced it has awarded $1,996,745 million to 16 laboratories through its Individual Research Grants Program. At the forefront of molecular and cellular studies, CDRF's Individual Research Grant Program is the Foundation's largest, most comprehensive research initiative. The grants awarded today represent an overall $77 million commitment to research by the Foundation since 1982.

"The Individual Grants Research Program plays an integral role in allowing scientists to gather the preliminary data necessary to secure larger, more long-term support from the National Institutes of Health (NIH) and other funding agencies," said Susan Howley, Director of Research and Executive Vice President of CDRF. "Supporting this kind of basic research is the key to the development of therapies for paralysis caused by spinal cord injury and a host of other central nervous system disorders."

Each of the CDRF grant recipients will use the money to fund research that supports investigator-initiated research on a variety of fronts, including axon growth and guidance, remyelination, cellular replacement, rehabilitation and neuroprotection.

"From brain-controlled prosthetics and stem cell manipulation to the use of non-spinal cord injury drugs to regenerate nerve fibers, this year, the grants represent a diverse portfolio, including many rehabilitation grants which prove that translation research is moving forward," said Moses Chao, Ph.D., Professor of Cell Biology and Neuroscience at NYU School of Medicine and Chairman of CDRF's Science Advisory Council. "I
'/>"/>

SOURCE The Christopher and Dana Reeve Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
2. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
3. Champalimaud Foundation Unveils C-TRACER in Hyderabad, India
4. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
5. Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule
6. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
7. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety
8. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
9. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
10. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
11. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... that American Indians largely were wiped out by diseases ... brought to the New World by European explorers., One ... lived in the Americas shortly before Europeans arrived, and ... diseases., But new research led by anthropological geneticists Anne ... the University of Tubingen in Germany indicates the diagnosis ...
(Date:8/20/2014)... Group finds that the vascular access device market in ... and China (BRIC) was valued ... of the United States market that year. ... as a result of strong economic expansion, improving access to healthcare ... Resources Group,s coverage of the BRIC vascular access device market: ...
(Date:8/20/2014)... JOSE, Calif. , Aug. 20, 2014 /PRNewswire-iReach/ ... highlights the transformative collaboration between the school,s bioengineering ... As part of the Intel® Software Academic Program, ... computer sciences and the human body.  ... The study exhibits the work of Dr. ...
(Date:8/19/2014)... August 20, 2014 One of ... medicine is an inadequate vascular supply. Nutrient and ... decellularized tissues is critical for successful regeneration and ... to mitigate deficiencies in vascularization and promote angiogenesis ... bioactivity, optimizing scaffold design and architecture, and enhancing ...
Breaking Biology Technology:Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2
... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: DNDN ) ... offering have exercised in full their option to purchase an ... price of $24.75 per share. The exercise of the ... of 17,250,000 shares of common stock. Dendreon expects to ...
... , SAN DIEGO, Dec. 11 Ambit ... Texas M. D. Anderson Cancer Center of the first patient in the ... Phase 2 pivotal trial in patients with relapsed or refractory acute myeloid ... selective small molecule that was specifically designed as a FMS-like tyrosine kinase-3 ...
... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ... of Dr. Alan Warrander to the role of Senior ... Warrander will be responsible for the execution of the ... President and CEO of Oncolytics. "Having reached an agreement ...
Cached Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
(Date:8/21/2014)... A landmark study aimed at improving the food intake, ... long-term care homes is among three projects at the ... grants from the Canadian Institutes of Health Research (CIHR). ... Applied Health Sciences at Waterloo, and a Schlegel research ... two years to investigate why many Canadians living in ...
(Date:8/21/2014)... Saturday to Wednesday, Oct. 18-22, 2014 , ... Harbor Drive, San Diego, CA 92101 , ... other presentations of the latest research in human ... session featuring high-scoring abstracts on rare genetic variants ... cancers, and treatment for sun sensitivity (Saturday, Oct. ...
(Date:8/21/2014)... Researchers from North Carolina State University have developed a ... The model has applications for creating new materials as ... , "Our new technique allows us to model much ... so much more quickly," says Nan Li, lead author ... student in NC State,s Department of Materials Science and ...
Breaking Biology News(10 mins):Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2Researchers develop models to study polyelectrolytes, including DNA and RNA 2
... NOAA/Virginia Sea Grant has awarded Virginia Tech $119,000 to ... virus in both shucked and unshucked oysters. , The ... High Pressure Processing Laboratory, and Laura Douglas, lab manager, ... schedules. The laboratory is a facility of the Department ...
... a new protein that plays a critical role in enabling ... or stress, as well as in the progressive loss of ... Their findings, they said, suggest new approaches to prevent or ... in the U.S. The team reports its findings in the ...
... lifespan in yeast, worms, and flies keeps blood sugar ... the August Cell Metabolism. The findings suggest therapeutic interventions ... as type 2 diabetes, which frequently arise with age, ... with an excess of the protein Sirt1 in cells ...
Cached Biology News:Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied 2Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy 2Life-extending protein keeps blood sugar in check 2
... Protein Purification Plates are designed for quick ... The 96-well plates feature two 0.25mm holes ... each well. The wells remain liquid-tight during ... during which time the protein diffuses from ...
... the state-of-the-art in permanent mounting media. ... preservation of immunohistochemical organic insoluble substrates ... New Fuchsin, and any other organic ... sections. Clarin can be used for ...
... industry's first siRNA sequence design software in ... these tools consistent with new experimental strategies ... of RNAi. With the introduction of ... tools, OligoEngine is pleased to offer the ...
... been designed and created in order to ... genotyping analysis tool. We incorporated the suggestions ... the software. Their main requirements were ease- ... acquisition cost. GeneMarker can perform analysis ...
Biology Products: